Table 3.
Status of physostigmine administration in patients
| Out come | Physostigmine administration, count (%) | Total, count (%) | |
|---|---|---|---|
|
| |||
| No | Yes | ||
| Major effects | 2172 (94.9) | 116 (5.1) | 2288 (100.0) |
| Minor effects | 31,320 (99.9) | 45 (0.1) | 31,365 (100.0) |
| Moderate effects | 19,659 (97.8) | 449 (2.2) | 20,108 (100.0) |
| Total | 53,151 (98.9) | 610 (1.1) | 53,761 (100.0) |